Travere Therapeutics
TVTX
#4846
Rank
C$1.89 B
Marketcap
$21.30
Share price
-9.48%
Change (1 day)
125.70%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2023 (TTM): -$6.10

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.42. In 2022 the company made an earnings per share (EPS) of -$6.21 a decrease over its 2021 EPS that were of -$4.31.

EPS history for Travere Therapeutics from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.10-1.74%
2022-$6.2144.22%
2021-$4.31-10.09%
2020-$4.79-2.6%
2019-$4.9236.22%
2018-$3.6164.94%
2017-$2.1920.31%
2016-$1.82-135.46%
2015$5.13-175.68%
2014-$6.7898.75%
2013-$3.411746.15%
2012-$0.181.34%
2011-$0.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.42-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.38-94.03%๐Ÿ‡บ๐Ÿ‡ธ USA